[Possibilities and limits of pharmacotherapy of chronic venous insufficiency].
The conservative therapy of the chronic venous insufficiency is always carried out with etiopathogenetic orientation and according to the stages of disease. Of the medicamentous therapy oedema-protective and vein-tonicising drugs, oral anticoagulants and non-steroidal antiphlogistics are discussed. Furthermore, the alternative and supplementary prescription of physiotherapy and movement cure depending on findings is dealt with.
Institut für Klinische Pharmakologie, Karl-Marx-Universität Leipzig.
R
R
Regenthal
H
H
Voigt
K
K
Grossmann
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D002123:Calcium Dobesilate / Q000627:therapeutic use; D004087:Dihydroergotamine / Q000627:therapeutic use; D006801:Humans; D008209:Lymphedema / Q000517:prevention & control; D013924:Thrombophlebitis / Q000188:drug therapy; D014689:Venous Insufficiency / Q000188:drug therapy*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000925:Anticoagulants; D004087:Dihydroergotamine; D002123:Calcium Dobesilate
Möglichkeiten und Grenzen der Pharmakotherapie der chronisch-venösen Insuffizienz.